Chris Baker
Investitore di Private Equity presso Lifearc Ventures
Profilo
Chris joined LifeArc as Investment Principal at LifeArc Ventures in 2021.
He is responsible for new investments and managing existing portfolio companies.
Chris has held key business development roles in the investment and charity research industries, sourcing, assessing and converting life science opportunities.
Previously, he was an Associate at the?trans-Atlantic venture investor?Advent Life Sciences, leading the diligence on a range of therapeutic and medical device opportunities, and supporting the growth of several portfolio companies.
Chris worked for ten years in the University technology transfer sector with UCL Business and Cancer Research Technology.
He successfully?supported and commercialised a number of oncology and gene and cell therapy opportunities, and?in addition, he was involved in executing a number of strategic initiatives such as the CRUK Stratified Medicine Programme and Grand Challenge awards.
Chris received his M.Biochem from the University of Oxford and a PhD in Genetics from the University of Cambridge in the lab of Prof.
Fiona Watt.
Posizioni attive di Chris Baker
| Società | Posizione | Inizio |
|---|---|---|
Lifearc Ventures
 Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/10/2021 |
Precedenti posizioni note di Chris Baker
| Società | Posizione | Fine |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Analista di Private Equity | 01/09/2021 |
UCL Business Ltd.
 UCL Business Ltd. Miscellaneous Commercial ServicesCommercial Services UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/07/2019 |
| Acublate Ltd. | Direttore/Membro del Consiglio | 01/03/2017 |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/10/2016 |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/12/2015 |
Formazione di Chris Baker
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
UCL Business Ltd.
UCL Business Ltd. Miscellaneous Commercial ServicesCommercial Services UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Commercial Services |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
| Acublate Ltd. | Health Technology |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Chris Baker
